Lactoferrin ameliorates carfilzomib-induced renal and pulmonary deficits: Insights to the inflammasome NLRP3/NF-κB and PI3K/Akt/GSK-3β/MAPK axes
出版年份 2023 全文链接
标题
Lactoferrin ameliorates carfilzomib-induced renal and pulmonary deficits: Insights to the inflammasome NLRP3/NF-κB and PI3K/Akt/GSK-3β/MAPK axes
作者
关键词
-
出版物
LIFE SCIENCES
Volume -, Issue -, Pages 122245
出版商
Elsevier BV
发表日期
2023-11-04
DOI
10.1016/j.lfs.2023.122245
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Potential of Lactoferrin in the Treatment of Lung Diseases
- (2023) Katarzyna Kaczyńska et al. Pharmaceuticals
- Lactoferrin alleviates cyclophosphamide induced-nephropathy through suppressing the orchestration between Wnt4/β-catenin and ERK1/2/NF-κB signaling and modulating klotho and Nrf2/HO-1 pathway
- (2023) Ola S. Mohamed et al. LIFE SCIENCES
- Lactoferrin and Nanotechnology: The Potential for Cancer Treatment
- (2023) Tuan Hiep Tran et al. Pharmaceutics
- Carfilzomib-induced life-threatening lung injury in refractory multiple myeloma
- (2023) Rola Ghasoub et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Bovine Lactoferrin Induces Cell Death in Human Prostate Cancer Cells
- (2022) Vanessa P. Rocha et al. Oxidative Medicine and Cellular Longevity
- Effects of Curcumin and Lactoferrin to Inhibit the Growth and Migration of Prostatic Cancer Cells
- (2022) Erica Costantini et al. International Journal of Environmental Research and Public Health
- Lactoferrin: A Glycoprotein Involved in Immunomodulation, Anticancer, and Antimicrobial Processes
- (2021) Quintín Rascón-Cruz et al. MOLECULES
- Inhibitory effects of lactoferrin on pulmonary inflammatory processes induced by lipopolysaccharide through modulating the TLR4-related pathway
- (2021) H.Y. Li et al. JOURNAL OF DAIRY SCIENCE
- GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis
- (2021) Francesco Cinetto et al. Frontiers in Molecular Biosciences
- Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways
- (2021) Shaimaa S. Ibrahim et al. NEUROPHARMACOLOGY
- Potential therapeutic antipsychotic effects of Naringin against ketamine-induced deficits in rats: Involvement of Akt/GSK-3β and Wnt/β-catenin signaling pathways
- (2020) Mina Y. George et al. LIFE SCIENCES
- Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials
- (2020) Somedeb Ball et al. ANNALS OF HEMATOLOGY
- Targeting cancer with lactoferrin nanoparticles: recent advances
- (2020) Anand K Kondapi Nanomedicine
- The role of glycogen synthase kinase 3 beta in multiple sclerosis
- (2020) Tayebeh Noori et al. BIOMEDICINE & PHARMACOTHERAPY
- Rutin inhibits carfilzomib-induced oxidative stress and inflammation via the NOS-mediated NF-κB signaling pathway
- (2019) Naif O. Al-Harbi et al. INFLAMMOPHARMACOLOGY
- Carfilzomib for relapsed and refractory multiple myeloma
- (2019) K. Groen et al. Cancer Management and Research
- The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
- (2019) Nathan Kelley et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lactoferrin Protects Hyperoxia-Induced Lung and Kidney Systemic Inflammation in an In Vivo Imaging Model of NF-κB/Luciferase Transgenic Mice
- (2019) Chih-Ching Yen et al. MOLECULAR IMAGING AND BIOLOGY
- Lactoferrin: major physiological functions and applications
- (2018) Liyuan Hao et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Carfilzomib-Associated Cardiovascular Adverse Events
- (2018) Adam J. Waxman et al. JAMA Oncology
- Apremilast ameliorates carfilzomib-induced pulmonary inflammation and vascular injuries
- (2018) Faisal Imam et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Carfilzomib Pulmonary Toxicity
- (2016) Anita Bhagavath et al. CHEST
- Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma
- (2016) Rimda Wanchoo et al. Clinical Journal of the American Society of Nephrology
- Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
- (2016) Meletios A Dimopoulos et al. LANCET ONCOLOGY
- A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)
- (2016) R Hájek et al. LEUKEMIA
- Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats
- (2016) Faisal Imam et al. TOXICOLOGY MECHANISMS AND METHODS
- Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?
- (2016) A Rosenthal et al. Blood Cancer Journal
- Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats
- (2016) Faisal Imam et al. TOXICOLOGY MECHANISMS AND METHODS
- Fatal pulmonary hemorrhage after carfilzomib treatment in multiple myeloma
- (2015) Yok-Lam Kwong ANNALS OF HEMATOLOGY
- Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study
- (2015) Eli Muchtar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
- (2015) A. Keith Stewart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Case series discussion of cardiac and vascular events following carfilzomib treatment: possible mechanism, screening, and monitoring
- (2014) Ajai Chari et al. BMC CANCER
- Bovine lactoferrin inhibits lung cancer growth through suppression of both inflammation and expression of vascular endothelial growth factor
- (2013) Yu-Tang Tung et al. JOURNAL OF DAIRY SCIENCE
- Endoplasmic Reticulum Stress and the Unfolded Protein Response: Targeting the Achilles Heel of Multiple Myeloma
- (2013) L. Vincenz et al. MOLECULAR CANCER THERAPEUTICS
- Bovine lactoferrin ameliorates ferric nitrilotriacetate-induced renal oxidative damage in rats
- (2012) Yasumasa Okazaki et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Protective Effect of Lactoferrin on Cisplatin-Induced Nephrotoxicity in Rats
- (2012) Yumi KIMOTO et al. JOURNAL OF VETERINARY MEDICAL SCIENCE
- Radiation-induced changes in breathing frequency and lung histology of C57BL/6J mice are time- and dose-dependent
- (2012) T. Eldh et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
- (2011) S. Arastu-Kapur et al. CLINICAL CANCER RESEARCH
- Glycogen synthase kinase 3: A point of convergence for the host inflammatory response
- (2010) Huizhi Wang et al. CYTOKINE
- GSK3 Promotes Apoptosis after Renal Ischemic Injury
- (2010) Z. Wang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis
- (2010) Nanchang Xie et al. NEUROPHARMACOLOGY
- Role of Glycogen Synthase Kinase-3β in Cardioprotection
- (2009) Magdalena Juhaszova et al. CIRCULATION RESEARCH
- Lactoferrin as a Natural Regimen for Selective Decontamination of the Digestive Tract: Recombinant Porcine Lactoferrin Expressed in the Milk of Transgenic Mice Protects Neonates from Pathogenic Challenge in the Gastrointestinal Tract
- (2009) Chih‐Ching Yen et al. JOURNAL OF INFECTIOUS DISEASES
- Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)
- (2009) Eléonore Beurel et al. TRENDS IN IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now